In vitro effects of 5-hydroxytryptamine and cisapride on the circular smooth muscle of the jejunum of horses

American Journal of Veterinary Research

Volumn 61, Issue 12, 2000, Pages 1561-1565

  Nieto, Jorge E ^a   Snyder, Jack R ^a   Kollias Baker, Cynthia ^a   Stanley, Scott ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CISAPRIDE; KETANSERIN TARTRATE; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; HORSE; ILEUS; INTESTINE MUSCLE; JEJUNUM; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; POSTOPERATIVE COMPLICATION;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0033662547     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.1561     Document Type: Article

References (40)

1. Gerring EL, Hunt JM. Pathophysiology of equine postoperative ileus: effect of adrenergic blockade, parasympathetic stimulation and metoclopramide in an experimental model. Equine Vet J 1986;18:249-255.
2. MacDonald MH, Pascoe JR, Stover SM, et al. Survival after small intestine resection and anastomosis in horses. Vet Surg 1989; 18:415-423.
3. Blikslager AT, Bowman KF; Levine JF; et al. Evaluation of factors associated with postoperative ileus in horses: 31 cases (1990-1992). J Am Vet Med Assoc 1994;205:1748-1752.
4. Hunt MJ, Edward GB, Clarke KW Incidence, diagnosis and treatment of postoperative complications in colic cases. Equine Vet J 1986;18:264-270
5. King JN, Gerring EL. The action of low dose endotoxin on equine bowel motility. Equine Vet J 1991;23:11-17.
6. White NA. Treatment to alter intestinal motility. In: White NA, ed. The equine acute abdomen. Malvern, Pa: Lea & Febiger, 1990;178-184.
7. Lester GD. Disorders of equine GI motility and the use of prokinetic drugs, in Proceedings. Annu Meet Vet Med Forum Am Coll Vet Intern Med 1994;603-606.
8. Tonini M. Recent advances in the pharmacology of gastrointestinal prokinetics. Pharmacol Res 1996;33:217-226.
9. De Geest J, Vlaminck K, Muylle E, et al. A clinical study of cisapride in horses after colic surgery. Equine Vet Educ 1991;3: 138-142.
10. Gerring EL, King JN. A multicentre trial of cisapride in the prophylaxis of equine post operative ileus. Equine Vet Educ 1991; 3:143-145.
11. van der Velden MA, Klein WR. The effect of cisapride on the restoration of gut motility after surgery of the small intestine in horses; a clinical trial. Vet Q 1993;15:175-179.
12. Gerring EL, King JN. Cisapride in the prophylaxis of equine post operative ileus. Equine Vet J 1989;7(suppl):52-55.
13. Valk N, Doherty J, Blackford JT, et al. Effect of cisapride on gastric emptying following endotoxin treatment. Equine Vet J 1998; 30:344-348.
14. King JN, Gerring EL. Cisapride does not modify equine gastrointestinal motility disrupted by E. coli endotoxin or prostaglandin E2. J Gastrointest Motil 1992;4:261-269.
15. Gershon MD, Wade PR, Kirchgessner AL, et al. 5-HT receptor subtypes outside the central nervous system. Roles in the physiology of the gut. Neuropsychopharmacology 1990;3:385-395.
16. Read NW, Gwee KA. The importance of 5-hydroxytryptamine receptors in the gut. Pharmacol Ther 1994;62:159-173.
17. Hoyer D, Clarke DE, Fozard JR, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-203.
18. Zifa E, Fillion G. 5-Hydroxytryptamine receptors. Pharmacol Rev 1992;44:401-458.
19. Prins NH, Briejer MR, Schuurkes JAJ. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle. Br J Pharmacol 1997;120:714-720.
20. Tam FS, Hillier, Bunce KT. Characterization of the 5-hydroxytryptamine receptor type involved in inhibition of spontaneous activity of human isolated colonic circular muscle. Br J Pharmacol 1994;113:143-150.
21. de Ridder WJE, Schuurkes JAJ. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine 1,2,3,4 receptors. J Pharmacol Exp Ther 1993;264:79-88.
22. Woollard DJ, Bornstein JC Furness JB. Characterization of 5-HT receptors mediating contraction and relaxation of the longitudinal muscle of guinea-pig distal colon in vitro. Naunyn Schmiedebergs Arch Pharmacol 1994;349:455-462.
23. Herlihy JT, Murphy RA. Length-tension relationship of smooth muscle of the hog carotid artery. Circ Res 1973;33:275-283.
24. Chen HT, Goh MH, Pan S. The effect and mechanism of the prokinetic action of cisapride on gastrointestinal smooth muscle. Gastroenterol Jpn 1993;28:218-223.
25. Briejer MR, Mathis C, Schuurkes JA. 5-HT receptor types in the rat ileum longitudinal muscle: focus on 5-HT2 receptors mediating contraction. Neurogastroenterol Motil 1997;9:231-237.
26. Washabau RJ, Hall JA. Gastrointestinal prokinetic therapy: serotonergic drugs. Compend Contin Educ Pract Vet 1997;19:473-480.
27. Schuurkes JAJ, Van Nueten JM, Van Daele PGH, et al. Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig. J Pharmacol Exp Ther 1985;234: 775-783.
28. Nakayama S, Neya T, Yamasato T, et al. Effect of cisapride on the motility of digestive tract in clogs and guinea pigs. Jpn J Smooth Muscle Res 1985;21:1-9.
29. Cook G, Papich MG, Roberts MC, et al. Pharmacokinetics of cisapride in horses after intravenous and rectal administration. Am J Vet Res 1997;58:1427-1430.
30. Taniyama K, Nakayama S, Takeda K, et al. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J Pharmacol Exp Ther 1991;258:1098-1104.
31. Craig DA, Clarke DE. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor J Pharmacol Exp Ther 1990;252:1378-1386.
32. Briejer MR, Akkermans LM, Schuurkes JA. Interactions of serotonin with multiple receptors and neurotransmitters in the guinea pig isolated colon. Arch Int Pharmacodyn Ther 1995;329: 121-133.
33. Haga N, Suzuki H, Shiba Y, et al. Effect of TKS159, a novel 5-hydroxytryplamine4 agonist, on gastric contractile activity in conscious dogs. Neurogastroenterol Motil 1998;10:295-303.
34. Graf S, Sarna SK. 5-HT-induced jejunal motor activity: enteric locus of action and receptor subtypes. Am J Physiol 1996;270: 992-1000.
35. Jaffe BM, Ferrara A, Sherlock DJ. Comparative effects of ketanserin, atropine and methysergide on the gastrointestinal effects of hyperserotoninemia in the awake dog. J Pharmacol Exp Ther 1986; 238:536-541.
36. Jin JG, Foxx-Orenstein AE, Grider JR. Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors. J Pharmacol Exp Ther 1999;288:93-97.
37. Nagakura Y, Kamato T, Nishida A, et al. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs. Naunyn Schmiedebergs Arch Pharmacol 1996;353(5):489-498.
38. Ng WW, Jing J, Hyman PE, et al. Effect of 5-hydroxytryptamine and its antagonists on colonie smooth muscle of the rabbit. Dig Dis Sci 1991;36:168-173.
39. Richardson BP, Engel G, Donatsch P, et al. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 1985;316:126-131.
40. Dumuis A, Bouhelal R, Sebben M. et al. A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930. Eur J Pharmacol 1988;146: 187-188.